Data / Form D filings / Sprout Pharmaceuticals, Inc.
Sprout Pharmaceuticals, Inc.: Form D filings
Sprout Pharmaceuticals, Inc., a pharmaceuticals company in Raleigh, NC, filed 7 Form D notices with the SEC between 2012 and 2015. The latest, on June 8, 2015, reports $50 million sold of a $50 million offering to 5 investors.
Find out what Sprout Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4208 SIX FORKS ROAD, SUITE 1010, Raleigh, NC, 27609
- Phone
- (919) 882-0850
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2011
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1545211
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 8, 2015 | New notice | $50,000,008 | $50,000,008 | $0 | 5 | May 22, 2015 | sec.gov |
| Jul 11, 2014 | New notice | $15,000,000 | $4,303,856 | $10,696,144 | 69 | Jun 30, 2014 | sec.gov |
| Jul 26, 2013 | Amendment | $10,000,000 | $9,999,997 | $3 | 88 | Jun 11, 2013 | sec.gov |
| Jun 25, 2013 | New notice | $10,000,000 | $4,791,913 | $5,208,087 | 63 | Jun 11, 2013 | sec.gov |
| Jul 11, 2012 | Amendment | $20,000,000 | $20,000,000 | $0 | 59 | Jun 15, 2012 | sec.gov |
| Jun 29, 2012 | New notice | $20,000,000 | $17,554,341 | $2,445,659 | 55 | Jun 15, 2012 | sec.gov |
| Mar 21, 2012 | New notice | $5,000,000 | $5,000,000 | $0 | 61 | Mar 8, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anne S. Tomalin | Executive Officer | |
| Anthony S. Wild | Director | |
| Matthew S. Petzold | Executive Officer | |
| Douglas S. Eckert | Executive Officer, Director | |
| Robert S. Whitehead | Executive Officer, Director | |
| Josephine S. Torrente | Executive Officer | |
| James S. Pruden | Executive Officer | |
| Rich S. Franco | Executive Officer | |
| Braxton Robert Goodrich | Director | |
| Richard Robert DeSchutter | Director | |
| W. Robert Dahl | Director | |
| Trygve Robert Mikkelsen | Director | |
| Michael Robert Ford | Director | |
| Cynthia Whitehead | Executive Officer, Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Jun 8, 2015 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Sprout Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.